Mount Yale Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Mount Yale Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $364,958 - $486,746	-1,763 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $203,497 - $241,267	796 Added 82.32%	1,763 $480,000
Q2 2020 Jul 09, 2020	BUY	$225.48 - $295.8 $218,039 - $286,038	967 New	967 $281,000
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $133,680 - $169,144	-880 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $7,212 - $8,287	43 Added 5.14%	880 $162,000
Q2 2018 Aug 22, 2018	BUY	$145.72 - $169.96 $31,912 - $37,221	219 Added 35.44%	837 $142,000
Q1 2018 Jun 25, 2018	BUY	$151.6 - $177.13 $93,688 - $109,466	618 New	618 $101,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.